Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer. (10th October 2017)

Record Type:: Journal Article
Title:: Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer. (10th October 2017)
Main Title:: Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer
Authors:: García‐Carbonero, Rocío
van Cutsem, Eric
Rivera, Fernando
Jassem, Jacek
Gore, Ira
Tebbutt, Niall
Braiteh, Fadi
Argiles, Guillem
Wainberg, Zev A.
Funke, Roel
Anderson, Maria
McCall, Bruce
Stroh, Mark
Wakshull, Eric
Hegde, Priti
Ye, Weilan
Chen, Daniel
Chang, Ilsung
Rhee, Ina
Hurwitz, Herbert
Abstract:
Is Part Of:: Oncologist. Volume 22:Number 10(2017)
Journal:: Oncologist
Issue:: Volume 22:Number 10(2017)
Issue Display:: Volume 22, Issue 10 (2017)
Year:: 2017
Volume:: 22
Issue:: 10
Issue Sort Value:: 2017-0022-0010-0000
Page Start:: 1281
Page End:: 1281
Publication Date:: 2017-10-10
Subjects:: Oncology -- Periodicals
Tumors -- Periodicals
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Oncology
Tumors
Neoplasms
Electronic journals
Periodicals
Periodicals
616.994
Journal URLs:: https://academic.oup.com/oncolo ↗
https://theoncologist.onlinelibrary.wiley.com/journal/1549490x ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1634/theoncologist.2016-0133erratum ↗
Languages:: English
ISSNs:: 1083-7159
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6256.890000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23774.xml